June 26, 2025
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Patients with systemic lupus erythematosus who received autologous chimeric antigen receptor T-cell therapy enjoyed potent B-cell depletion and recovery, as well as improved disease activity, said a presenter at the EULAR 2025 Congress.“We’ve seen already today another presentation on CAR-T therapies and related approaches showing great promise in deep B-cell depletion, leading to
June 26, 2025
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

A dual-target CD19/BCMA chimeric antigen receptor T-cell therapy yielded “profound, sustained” remission in 11 patients with…

Stay up to date with notifications from The IndependentNotifications can be managed in browser preferences.Jump to contentThank…

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

Explore the potential of CAR-T therapy as a groundbreaking treatment for autoimmune diseases, offering long-term remission…

The therapy works by genetically modifying cells to enable the body’s own immune system to recognise and attack problem cells

The therapy works by genetically modifying cells to enable the body’s own immune system to recognise and attack problem cells